Key result
Renin-angiotensin blockade for diabetic retinopathy is evaluated using an Italian population risk function.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Model-based evaluation leaves open renin-angiotensin blockade benefit in diabetic retinopathy; prospective trials required before any practice consideration.
with risk function from an Italian population study.
No takes yet. Share an insight, caveat, or question.
Ghattas et al. (2011) studied this question. Renin-angiotensin blockade for diabetic retinopathy was evaluated using a risk function from an Italian population study.
Synapse has enriched 10 related papers. Consider them for comparative context: